| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MED.21443 |
| P8608 | Fatcat ID | release_qfdwiygtjrhphnuvw4nndgevei |
| P698 | PubMed publication ID | 28815732 |
| P50 | author | Matthias D'hooghe | Q56441897 |
| Izidor Sosič | Q41595018 | ||
| P2093 | author name string | Stanislav Gobec | |
| Marko Jukič | |||
| Lena Decuyper | |||
| Aleš Žula | |||
| P2860 | cites work | In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens | Q42255874 |
| In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii | Q42695527 | ||
| Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms | Q42905476 | ||
| Azetidinone-isothiazolidinones: stereoselective synthesis and antibacterial evaluation of new monocyclic beta-lactams | Q43103785 | ||
| Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'. | Q43225854 | ||
| Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters | Q43227345 | ||
| Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors | Q43764227 | ||
| Aztreonam: the first monobactam | Q44061792 | ||
| Synthesis of potent and highly selective inhibitors of human tryptase | Q44173956 | ||
| N-Thiolated beta-lactam antibacterials: defining the role of unsaturation in the C4 side chain | Q44241684 | ||
| Stereoselective synthesis of beta-lactams with polyaromatic imines: entry to new and novel anticancer agents | Q44262325 | ||
| In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production | Q44426404 | ||
| Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. | Q44841673 | ||
| Mutational analysis and characterization of nocardicin C-9' epimerase | Q44976863 | ||
| The biosynthetic gene cluster for a monocyclic beta-lactam antibiotic, nocardicin A. | Q44991128 | ||
| Catalysis of Hydrolysis and Aminolysis of Non-classical .BETA.-Lactam Antibiotics by Metal Ions and Metal Chelates | Q45049683 | ||
| Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters | Q45431531 | ||
| Siderophores as drug delivery agents: application of the "Trojan Horse" strategy | Q46123128 | ||
| Monocyclic β-lactams as antibacterial agents: facing antioxidant activity of N-methylthio-azetidinones. | Q46172671 | ||
| Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives | Q46577174 | ||
| Synthesis and reactivity with beta-lactamases of a monobactam bearing a retro-amide side chain | Q46814490 | ||
| Synthesis and biological activity of N-substituted-3-chloro-2-azetidinones. | Q46861259 | ||
| Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4-thiadiazino (6,5-b) indoles as promising anti-inflammatory agents | Q46863293 | ||
| Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli | Q46884279 | ||
| Synthesis and antimicrobial activity of some new sugar-based monocyclic beta-lactams | Q46896953 | ||
| Non-transpeptidase binding arylthioether β-lactams active against Mycobacterium tuberculosis and Moraxella catarrhalis | Q50442245 | ||
| Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion. | Q52076636 | ||
| ??? | Q59205096 | ||
| Three decades of beta-lactamase inhibitors | Q24646623 | ||
| Tigemonam, an oral monobactam | Q24674177 | ||
| Side chain SAR of bicyclic beta-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem | Q27658832 | ||
| Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa | Q27666204 | ||
| Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712 | Q27670446 | ||
| Distinctive attributes of β-lactam target proteins in Acinetobacter baumannii relevant to development of new antibiotics | Q27675361 | ||
| How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function | Q27680124 | ||
| Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections | Q27681974 | ||
| Pyridone-conjugated monobactam antibiotics with gram-negative activity | Q27684802 | ||
| Preparation and antibiotic activity of monobactam analogues of nocardicins. | Q30580254 | ||
| N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus | Q30705155 | ||
| Effect of aryl ring fluorination on the antibacterial properties of C4 aryl-substituted N-methylthio beta-lactams | Q30780735 | ||
| N-Methylthio beta-lactam antibacterials: effects of the C3/C4 ring substituents on anti-MRSA activity | Q31007299 | ||
| N-thiolated beta-lactams: a new family of anti-Bacillus agents. | Q31032280 | ||
| N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus | Q31096170 | ||
| Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease | Q33215093 | ||
| Design, synthesis, and biological evaluation of 4-alkyliden-beta lactams: new products with promising antibiotic activity against resistant bacteria | Q33241156 | ||
| Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2. | Q33601560 | ||
| Carbapenems and monobactams: imipenem, meropenem, and aztreonam | Q33604334 | ||
| Beta-lactamases and beta-lactamase inhibitors | Q33754336 | ||
| Monocyclic beta-lactam antibiotics produced by bacteria | Q34275938 | ||
| Discovery and development of new antimicrobial agents | Q34371891 | ||
| Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam | Q34425933 | ||
| Inhibition of Glutamine Synthetase from Pea by Tabtoxinine-beta-lactam | Q34520534 | ||
| Azetidinones as vasopressin V1a antagonists | Q34603610 | ||
| In vitro activity of BAL30072 against Burkholderia pseudomallei | Q35072096 | ||
| Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups | Q35100771 | ||
| In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608. | Q35254700 | ||
| beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact | Q35535598 | ||
| Synthesis and biological activity of substituted [[3(S)-(acylamino)-2-oxo-1-azetidinyl]oxy]acetic acids. A new class of heteroatom-activated beta-lactam antibiotics. | Q53787195 | ||
| Inhibition of the broad spectrum nonmetallocarbapenamase of class A (NMC-A) beta-lactamase from Enterobacter cloacae by monocyclic beta-lactams. | Q54080970 | ||
| Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. | Q54122051 | ||
| Production of a plasmid mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isolate. | Q54190508 | ||
| Nature of monocyclic beta-lactam antibiotic Nocardicin A to beta-lactamases. | Q54391640 | ||
| Aztreonam, the first monobactam. | Q54407373 | ||
| In-vitro antibacterial activity of AMA-1080. | Q54442048 | ||
| The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli. | Q54444637 | ||
| The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents. | Q54455070 | ||
| Monobactams--structure-activity relationships leading to SQ 26,776. | Q54527597 | ||
| Activity of carumonam and aztreonam against Klebsiella species. | Q54741094 | ||
| Antibacterial agents and cystic fibrosis: synthesis and antimicrobial evaluation of a series of N-thiomethylazetidinones | Q56984203 | ||
| Nocardicin A, a new monocyclic beta-lactam antibiotic. I. Discovery, isolation and characterization | Q67789226 | ||
| Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. II. Isolation, physico-chemical properties and structure determination | Q69802619 | ||
| Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. I. Discovery, production and biological activities | Q69946409 | ||
| Formadicins, new monocyclic .BETA.-lactam antibiotics of bacterial origin. II. Isolation, characterization and structures. | Q105032642 | ||
| In vitro evaluation of tigemonam, a novel oral monobactam | Q35536519 | ||
| In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic | Q35644656 | ||
| Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A | Q35759902 | ||
| Beta-lactam cholesterol absorption inhibitors | Q35848123 | ||
| Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with beta-lactam antibiotics containing catechol and analogous groups | Q36159138 | ||
| Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one | Q36165366 | ||
| Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. | Q36200010 | ||
| The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA). | Q36392365 | ||
| Syntheses and Biological Evaluations of Highly Functionalized Hydroxamate Containing and N-Methylthio Monobactams as Anti-Tuberculosis and β-Lactamase Inhibitory Agents | Q36603702 | ||
| Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin | Q36641842 | ||
| The monobactams | Q37477141 | ||
| A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems | Q37579796 | ||
| Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition | Q37731521 | ||
| The future of the β-lactams. | Q37796156 | ||
| 2-Azetidinone – A new profile of various pharmacological activities | Q37802617 | ||
| Exploiting bacterial iron acquisition: siderophore conjugates. | Q37990947 | ||
| Improving known classes of antibiotics: an optimistic approach for the future | Q38022874 | ||
| Siderophore conjugates | Q38076456 | ||
| One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams | Q38712471 | ||
| Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects | Q38792863 | ||
| Overcoming β-lactam resistance in Gram-negative pathogens | Q38862139 | ||
| Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols. | Q39513210 | ||
| Mode of action of beta-lactam antibiotics | Q39821116 | ||
| In vitro activity and beta-lactamase stability of a new monobactam, B0-1165 | Q39827945 | ||
| Modern beta-lactam antibiotics | Q39843101 | ||
| Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans | Q39849453 | ||
| Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam | Q39881215 | ||
| Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii | Q40086051 | ||
| Monocyclic β-lactam antibiotics | Q40168531 | ||
| Structure activity relationships among the monobactams | Q40193112 | ||
| Synthesis of anticancer beta-lactams: mechanism of action | Q40562450 | ||
| In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli | Q40751280 | ||
| Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria | Q40811794 | ||
| Mutational analysis of nocK and nocL in the nocardicin a producer Nocardia uniformis | Q40874675 | ||
| New directions in antibacterial research | Q41131274 | ||
| Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model | Q41469713 | ||
| In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents | Q41951838 | ||
| In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases | Q42111112 | ||
| Structure-activity relations of 4-fluoromethyl monobactams | Q42216599 | ||
| Heteroatom-activated beta-lactam antibiotics: considerations of differences in the biological activity of [[3(S)-(acylamino)-2-oxo-1-azetidinyl]oxy]acetic acids (oxamazins) and the corresponding sulfur analogues (thiamazins). | Q42223941 | ||
| Chemical modification of sulfazecin. Synthesis of 4-methoxycarbonyl-2-azetidinone-1-sulfonic acid derivatives | Q42250738 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 426-503 | |
| P577 | publication date | 2017-08-16 | |
| P1433 | published in | Medicinal Research Reviews | Q2436033 |
| P1476 | title | Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams | |
| P478 | volume | 38 |
| Q97425458 | 1,2,3-Triazole β-lactam conjugates as antimicrobial agents |
| Q64096189 | Application of the -Dibenzyl Protective Group in the Preparation of β-Lactam Pseudopeptides |
| Q58600399 | Catalytic enantioconvergent coupling of secondary and tertiary electrophiles with olefins |
| Q59809615 | Chemoenzymatic Approach toward the Synthesis of 3-O-(α/β)-Glucosylated 3-Hydroxy-β-lactams |
| Q61806967 | Polarclean as a Sustainable Reaction Medium for the Waste Minimized Synthesis of Heterocyclic Compounds |
| Q47575983 | Reactivity of 3-Oxo-β-lactams with Respect to Primary Amines-An Experimental and Computational Approach. |
| Q89944176 | Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors |
Search more.